Flagship Ventures Fund IV, LP

Track

Insider profile

Flagship Ventures Fund IV, LP's trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
455.34
Quantity 27,000
Value US$3,585,425
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-13 2024-12-13
PrS Proposed sale
27,000
455.34
US$3,585,425 		27,000 455.34 US$3,585,425